How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers

Blood Press. 2020 Apr;29(2):68-69. doi: 10.1080/08037051.2020.1726101. Epub 2020 Feb 12.

Authors

Michel Burnier¹, Sverre E Kjeldsen², Krzysztof Narkiewicz³, Suzanne Oparil⁴

Affiliations

¹ Service of Nephrology and Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
² Department of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway.
³ Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland.
⁴ Vascular Biology and Hypertension Program, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

PMID: 32049554
DOI: 10.1080/08037051.2020.1726101

No abstract available

Publication types

Editorial

MeSH terms

Angiotensin II Type 1 Receptor Blockers / adverse effects*
Antihypertensive Agents / adverse effects*
Celiac Disease / chemically induced*
Celiac Disease / diagnosis
Celiac Disease / epidemiology
Humans
Hypertension / drug therapy*
Incidence
Olmesartan Medoxomil / adverse effects*
Patient Safety
Risk Assessment
Risk Factors

Substances

Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents
Olmesartan Medoxomil